Mukka Proteins Limited (IN:MUKKA)
:MUKKA
Want to see IN:MUKKA full AI Analyst Report?
Top Page
Mukka Proteins Limited
(MUKKA)
Select Model
Select Model
Rating:56Neutral
Price Target:
₹23.50
▼(-1.01% Downside)
Action:Reiterated
Date:05/19/26
The score is held back primarily by persistently negative operating/free cash flow and a renewed rise in debt despite strong revenue growth. Valuation is a positive (low P/E), while technical signals are mixed with price below key averages and only modest momentum support.
Positive Factors
Strong multi-year revenue growth
Consistent multi-year revenue growth, capped by a ~45% rebound in 2026, expands the company's scale and customer reach. A growing top line can improve capacity utilization, support fixed-cost absorption, and provide a firmer platform to invest in processing or export capabilities over the medium term.
Negative Factors
Persistent negative operating cash flow
Operating cash flow has been negative in most years and plunged to about -1.6B in 2026, showing reported earnings are not being converted to cash. Persistent OCF shortfalls force reliance on external financing, raise refinancing risk, and limit the firm's ability to self-fund working capital or investment.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong multi-year revenue growth
Consistent multi-year revenue growth, capped by a ~45% rebound in 2026, expands the company's scale and customer reach. A growing top line can improve capacity utilization, support fixed-cost absorption, and provide a firmer platform to invest in processing or export capabilities over the medium term.
Read all positive factors
Mukka Proteins Limited (MUKKA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹6.83B
Dividend YieldN/A
Average Volume (3M)40.24K
Price to Earnings (P/E)10.6
Beta (1Y)0.78
Revenue Growth44.02%
EPS Growth12.33%
CountryIN
Employees414
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)1.45
Shares Outstanding300,000,000
10 Day Avg. Volume18,929
30 Day Avg. Volume40,240
Financial Highlights & Ratios
PEG Ratio0.87
Price to Book (P/B)1.11
Price to Sales (P/S)0.38
P/FCF Ratio-1.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mukka Proteins Limited Business Overview & Revenue Model
Company Description
Mukka Proteins Limited manufactures and sells fish protein products in India. It offers fish meal, oil, and soluble paste. The company also offers insect meal and insect oil. The company's products are used as an ingredient for animal feed, poultr...
How the Company Makes Money
Mukka Proteins Limited primarily makes money by selling marine-based ingredients—mainly fish meal and fish oil—produced through processing marine raw materials. Its core revenue stream is product sales (domestic and export) to business customers s...
Mukka Proteins Limited Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
52
Neutral
Cash Flow
28
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.99B | 14.49B | 10.06B | 13.80B | 11.56B | 7.66B |
| Gross Profit | 2.24B | 2.23B | 2.32B | 1.69B | 1.34B | 799.87M |
| EBITDA | 1.06B | 1.15B | 948.84M | 1.22B | 962.04M | 550.04M |
| Net Income | 434.43M | 520.58M | 464.59M | 700.52M | 440.75M | 242.08M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 16.21B | 10.76B | 9.41B | 5.75B | 3.92B |
| Cash, Cash Equivalents and Short-Term Investments | 30.75M | 604.29M | 30.75M | 944.38M | 265.48M | 180.42M |
| Total Debt | 0.00 | 7.79B | 4.53B | 3.65B | 2.76B | 1.75B |
| Total Liabilities | -4.57B | 10.92B | 6.20B | 5.32B | 4.33B | 2.97B |
| Stockholders Equity | 4.57B | 4.99B | 4.41B | 3.96B | 1.34B | 898.23M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.97B | -1.36B | -1.68B | -737.46M | -63.29M |
| Operating Cash Flow | 0.00 | -1.59B | -1.12B | -1.50B | -655.31M | 1.82M |
| Investing Cash Flow | 0.00 | -1.46B | -349.86M | -475.94M | -53.83M | -142.25M |
| Financing Cash Flow | 0.00 | 3.15B | 555.53M | 2.66B | 746.65M | 158.58M |
Mukka Proteins Limited Technical Analysis
Negative
23.74
Price Trends
22.63
Positive
23.01
Positive
24.67
Negative
Market Momentum
0.20
Positive
47.86
Neutral
16.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MUKKA, the sentiment is Negative. The current price of 23.74 is below the 20-day moving average (MA) of 24.04, above the 50-day MA of 22.63, and below the 200-day MA of 24.67, indicating a neutral trend. The MACD of 0.20 indicates Positive momentum. The RSI at 47.86 is Neutral, neither overbought nor oversold. The STOCH value of 16.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MUKKA.
Mukka Proteins Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ₹172.61B | 17.33 | ― | 1.05% | 8.60% | 31.51% | |
65 Neutral | ₹10.36B | 9.32 | ― | 0.36% | 28.77% | 101.98% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ₹208.49B | 89.83 | ― | 0.61% | 14.48% | 27.72% | |
59 Neutral | ₹1.90B | 39.81 | ― | ― | 72.12% | -25.75% | |
56 Neutral | ₹6.83B | 10.63 | ― | ― | 44.02% | 12.33% | |
56 Neutral | ₹26.41B | 16.26 | ― | 0.33% | 11.23% | 9.51% |
* Consumer Defensive Sector Average
IN:MUKKA
Mukka Proteins Limited
22.75
-8.03
-26.09%
IN:AVANTIFEED
Avanti Feeds Limited
1,266.90
405.03
46.99%
IN:HATSUN
Hatsun Agro Product Limited
936.00
48.38
5.45%
IN:MKPL
M K Proteins Limited
5.05
-2.05
-28.87%
IN:PARAGMILK
Parag Milk Foods Ltd.
211.35
-1.67
-0.78%
IN:SKMEGGPROD
SKM Egg Products Export (India) Ltd.
196.75
93.87
91.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.